These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20821309)

  • 1. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study.
    Sèbe P; Doucet C; Cornu JN; Ciofu C; Costa P; de Medina SG; Pinset C; Haab F
    Int Urogynecol J; 2011 Feb; 22(2):183-9. PubMed ID: 20821309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy].
    Cornu JN; Doucet C; Sèbe P; Ciofu C; Gil Diez de Medina S; Vallancien G; Amarenco G; Cussenot O; Pinset C; Haab F
    Prog Urol; 2011 Nov; 21(12):859-65. PubMed ID: 22035912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence.
    Blaganje M; Lukanović A
    Int J Gynaecol Obstet; 2012 May; 117(2):164-7. PubMed ID: 22342057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients.
    Mitterberger M; Marksteiner R; Margreiter E; Pinggera GM; Colleselli D; Frauscher F; Ulmer H; Fussenegger M; Bartsch G; Strasser H
    BJU Int; 2007 Nov; 100(5):1081-5. PubMed ID: 17760890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence.
    Blaganje M; Lukanović A
    Int Urogynecol J; 2013 Apr; 24(4):533-5. PubMed ID: 23111866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial.
    Strasser H; Marksteiner R; Margreiter E; Pinggera GM; Mitterberger M; Frauscher F; Ulmer H; Fussenegger M; Kofler K; Bartsch G
    Lancet; 2007 Jun; 369(9580):2179-2186. PubMed ID: 17604800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cell therapy for stress urinary incontinence, short-term outcome.
    Shirvan MK; Alamdari DH; Mahboub MD; Ghanadi A; Rahimi HR; Seifalian AM
    Neurourol Urodyn; 2013 Apr; 32(4):377-82. PubMed ID: 22972395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral injection of autologous muscle precursor cells for treatment of female stress urinary incontinence: a prospective phase I clinical trial.
    Schmid FA; Prange JA; Kozomara M; Betschart C; Sousa RA; Steinke N; Hunziker M; Lehner F; Veit M; Grossmann R; Landsmann A; Hötker AM; Boss A; Mohr-Haralampieva D; Eberli D
    Int Urogynecol J; 2023 Sep; 34(9):2197-2206. PubMed ID: 37042972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult stem cell therapy of female stress urinary incontinence.
    Mitterberger M; Pinggera GM; Marksteiner R; Margreiter E; Fussenegger M; Frauscher F; Ulmer H; Hering S; Bartsch G; Strasser H
    Eur Urol; 2008 Jan; 53(1):169-75. PubMed ID: 17683852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study.
    Sharifiaghdas F; Tajalli F; Taheri M; Naji M; Moghadasali R; Aghdami N; Baharvand H; Azimian V; Jaroughi N
    Int J Urol; 2016 Jul; 23(7):581-6. PubMed ID: 27062371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.
    Carr LK; Steele D; Steele S; Wagner D; Pruchnic R; Jankowski R; Erickson J; Huard J; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jun; 19(6):881-3. PubMed ID: 18204978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Feasibility Study to Evaluate the Viveve System for Female Stress Urinary Incontinence: Interim 6-Month Report.
    Allan BB; Bell S; Husarek K
    J Womens Health (Larchmt); 2020 Mar; 29(3):383-389. PubMed ID: 31464548
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled clinical trial of an intravesical pressure-attenuation balloon system for the treatment of stress urinary incontinence in females.
    Wyndaele JJ; De Wachter S; Tommaselli GA; Angioli R; de Wildt MJ; Everaert KC; Michielsen DP; Van Koeveringe GA
    Neurourol Urodyn; 2016 Feb; 35(2):252-9. PubMed ID: 25598453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence.
    Strasser H; Marksteiner R; Margreiter E; Mitterberger M; Pinggera GM; Frauscher F; Fussenegger M; Kofler K; Bartsch G
    World J Urol; 2007 Aug; 25(4):385-92. PubMed ID: 17701044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.
    Jankowski RJ; Tu LM; Carlson C; Robert M; Carlson K; Quinlan D; Eisenhardt A; Chen M; Snyder S; Pruchnic R; Chancellor M; Dmochowski R; Kaufman MR; Carr L
    Int Urol Nephrol; 2018 Dec; 50(12):2153-2165. PubMed ID: 30324580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and demographic factors associated with valsalva leak point pressure among women undergoing burch bladder neck suspension or autologous rectus fascial sling procedures.
    Lemack GE; Xu Y; Brubaker L; Nager C; Chai T; Moalli P; Kraus SR; Kerr L; Sirls L; Stoddard A;
    Neurourol Urodyn; 2007; 26(3):392-6. PubMed ID: 17304525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of different surgical procedures for female stress urinary incontinence. Is stem cell implantation the future?
    Surcel C; Savu C; Chibelean C; Iordache A; Mirvald C; Sinescu I
    Rom J Morphol Embryol; 2012; 53(1):151-4. PubMed ID: 22395514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Transurethral and Transvaginal-Periurethral Injection of Autologous Adipose Derived Stem Cells for Treatment of Female Stress Urinary Incontinence: A Phase One Clinical Trial.
    Arjmand B; Safavi M; Heidari R; Aghayan H; T Bazargani S; Dehghani S; Goodarzi P; Mohammadi-Jahani F; Heidari F; Payab M; Pourmand G
    Acta Med Iran; 2017 Jun; 55(6):368-374. PubMed ID: 28843237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What if artificial urinary sphincter is not possible? Feasibility and effectiveness of ProACT for patients with persistent stress urinary incontinence after radical prostatectomy treated by sling.
    Munier P; Nicolas M; Tricard T; Droupy S; Costa P; Saussine C
    Neurourol Urodyn; 2020 Jun; 39(5):1417-1422. PubMed ID: 32249971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transurethral injections under local anaesthesia for ambulatory treatment of stress urinary incontinence in women: indications, feasibility and results].
    de Tayrac R; Cortesse A; Fernandez H; Fritel X
    J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 1):702-10. PubMed ID: 16270009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.